Astellas Pharma Inc (4503.T)
19 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|60||2017||President, Chief Executive Officer, Representative Director|
|2017||Chief Financial Officer, Executive Officer|
|2017||Chief Administrative Officer, Chief Ethics & Compliance Officer, Executive Officer|
|57||2017||Vice President, Chief Strategy Officer, Chief Commercial Officer, Representative Director|
|2017||Vice President - Real World Informatics & Analytics|
- Nikkei soars helped by exporters; drugmakers fall
- BRIEF-Astellas Pharma says application of marketing approval for blinatumomab in Japan
- BRIEF-Astellas acquires Mitobridge under existing collaboration
- UPDATE 4-Cytokinetics sinks on abandoning ALS drug after failed trial
- Astellas faces U.S. probe over patient assistance charity support